TERNS PHARMACEUTICALS INC. - COMMON STOCK

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

06 сен 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Upcoming September Investor Conferences

05 сен 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Updates

08 авг 2023 15:15:00 Источник Nasdaq GlobeNewswire

Terns Achieves Primary Endpoint and All Secondary Endpoints in Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH

08 авг 2023 15:05:02 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

03 авг 2023 17:00:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Leadership Transition

03 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss TERN-701 and Advances in the Treatment Landscape for Chronic Myeloid Leukemia

18 июл 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

05 июл 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Highlights New Preclinical Data for TERN-601 Program in Obesity at the ADA’s 83rd Annual Scientific Session and Upcoming Events

26 июн 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference

06 июн 2023 15:30:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

02 июн 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract for the 2023 ASCO Annual Meeting

25 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at Upcoming Investor Conferences

24 май 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions

22 май 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates

15 май 2023 07:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference

09 май 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

03 май 2023 15:05:01 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

27 мар 2023 15:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology

27 мар 2023 07:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences

02 мар 2023 15:05:00 Источник Nasdaq GlobeNewswire